Thyroid cancer: A review
L Boucai, M Zafereo, ME Cabanillas - JAMA, 2024 - jamanetwork.com
… Approximately 44 000 new cases of thyroid cancer are … Surgery is curative in most cases of
well-differentiated thyroid cancer… therapies to genetic mutations that give rise to thyroid cancer …
well-differentiated thyroid cancer… therapies to genetic mutations that give rise to thyroid cancer …
Thyroid cancer
O Gimm - Cancer letters, 2001 - Elsevier
… Thyroid cancer is considered to be a rare event in children and adolescents but its real
incidence is not known. Actually, about 10% of all thyroid cancers are diagnosed in this age group…
incidence is not known. Actually, about 10% of all thyroid cancers are diagnosed in this age group…
Thyroid cancer: molecular aspects and new therapeutic strategies
E Grande, JJ Díez, C Zafon… - Journal of Thyroid …, 2012 - Wiley Online Library
… Many entities are grouped under the general term of thyroid cancer, and they differ in …
thyroid cancer ranges from a survival rate of >97% at 5 years, in the case of differentiated thyroid …
thyroid cancer ranges from a survival rate of >97% at 5 years, in the case of differentiated thyroid …
[HTML][HTML] Thyroid cancer: burden of illness and management of disease
RL Brown, JA de Souza, EEW Cohen - Journal of Cancer, 2011 - ncbi.nlm.nih.gov
… Because recurrences have been reported sometimes decades from initial treatment, 9
patients with thyroid cancer require lifelong monitoring. Surveillance tests include measuring Tg …
patients with thyroid cancer require lifelong monitoring. Surveillance tests include measuring Tg …
The therapeutic management of differentiated thyroid cancer
JA Sipos, EL Mazzaferri - Expert opinion on pharmacotherapy, 2008 - Taylor & Francis
… Consequently, it is important to monitor TgAb levels in all thyroid cancer patients. Another
setting in which a patient may have an undetectable thyroglobulin in the face of clinical …
setting in which a patient may have an undetectable thyroglobulin in the face of clinical …
Expert consensus on the management of adverse events during treatment with lenvatinib for thyroid cancer
N Reed, H Glen, G Gerrard, J Good, M Lei, AR Lyon… - Clinical Oncology, 2020 - Elsevier
… The following should be monitored during treatment with lenvatinib for thyroid cancer. …
patients with advanced thyroid cancer on tyrosine kinase inhibitor therapy. Patients should have a …
patients with advanced thyroid cancer on tyrosine kinase inhibitor therapy. Patients should have a …
[HTML][HTML] Thyroid cancer: possible role of telemedicine
G Gibelli, B Gibelli, F Nani - Acta Otorhinolaryngologica Italica, 2008 - ncbi.nlm.nih.gov
… by telemedicine in cancer patient care have … thyroid hormones/heart interactions in thyroid
cancer patients have been taken into consideration and the possible use of distant monitoring …
cancer patients have been taken into consideration and the possible use of distant monitoring …
Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer
ME Cabanillas, MI Hu, JB Durand… - Journal of thyroid …, 2011 - Wiley Online Library
… We recommend that all patients initiating TKIs have a baseline echocardiogram and
periodic monitoring while they are on therapy. Furthermore, aggressive management of …
periodic monitoring while they are on therapy. Furthermore, aggressive management of …
Post-treatment surveillance of thyroid cancer
… As such, serum Tg levels are useful to monitor patients with differentiated thyroid cancer
after initial therapy. Tg values have the highest sensitivity and specificity for detection of …
after initial therapy. Tg values have the highest sensitivity and specificity for detection of …
Novel approaches to thyroid cancer treatment and response assessment
RK Grewal, A Ho, H Schöder - Seminars in nuclear medicine, 2016 - Elsevier
… effect on FDG-avid metastases 64 ), and may aid in treatment monitoring (a decline in
FDG uptake may indicate a response to novel targeted drugs in patients with advanced …
FDG uptake may indicate a response to novel targeted drugs in patients with advanced …